Hippuristanol inhibits the binding of mRNA to eIF4A and has been shown to reverse the resistance to chemotherapy and induce apoptosis in synergy with ABT-737 (BCL-2 inhibitor) in the Eμ-MYC lymphoma model [92]. This evidence concerns the gene MYC and lymphoma.